References
- Wang B, Zhang M, Ni YH, et al. Identification and characterization of NYGGF4, a novel gene containing a phosphotyrosine-binding (PTB) domain that stimulates 3T3-L1 preadipocytes proliferation. Gene 2006;379:132–40
- Caratu G, Allegra D, Bimonte M, et al. Identification of the ligands of protein interaction domains through a functional approach. Mol Cell Proteomics 2007;6:333–45
- Kajiwara Y, Franciosi S, Takahashi N, et al. Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer’s disease. Mol Neurodegener 2010;5:1
- Zhang CM, Chen XH, Wang B, et al. Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt. Acta Pharmacol Sin 2009;30:120–4
- Wu WL, Gan WH, Tong ML, et al. Over-expression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway. Mol Genet Metab 2011;102:374–7
- Bonala S, McFarlane C, Ang J, et al. Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity. Mol Endocrinol 2013;27:1518–35
- Zhang CM, Zeng XQ, Zhang R, et al. NYGGF4 homologous gene expression in 3T3-L1 adipocytes: regulation by FFA and adipokines. J Bioenerg Biomembr 2010;42:433–9
- Zeng XQ, Zhang CM, Tong ML, et al. Knockdown of NYGGF4 increases glucose transport in C2C12 mice skeletal myocytes by activation IRS-1/PI3K/AKT insulin pathway. J Bioenerg Biomembr 2012;44:351–5
- Zhao YP, Zhang CM, Zhu C, et al. NYGGF4 homologous gene expression in 3T3-L1 adipocytes: regulation by FFA and adipokines. Mol Biol Rep 2010;37:3291–6
- Zhao Y, Zhang C, Chen X, et al. Overexpression of NYGGF4 (PID1) induces mitochondrial impairment in 3T3-L1 adipocytes. Mol Cell Biochem 2010;340:41–8
- Chen X, Huang Z, Chen D, et al. Role of NYGGF4 in insulin resistance. Mol Biol Rep 2012;39:5367–71
- Yu Z, Guo X. NYGGF4 as a new therapeutic target for obesity-associated insulin resistance. Med Hypotheses 2012;78:432–4
- May P, Herz J, Bock HH. Molecular mechanisms of lipoprotein receptor signalling. Cell Mol Life Sci 2005;62:2325–38
- Boucher P, Herz J. Signaling through LRP1: protection from atherosclerosis and beyond. Biochem Pharmacol 2011;81:1–5
- Muratoglu SC, Mikhailenko I, Newton C, et al. Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-beta in endosomes and regulates activation of the MAPK pathway. J Biol Chem 2010;285:14308–17
- Loukinova E, Ranganathan S, Kuznetsov S, et al. Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function between LRP and the PDGF. J Biol Chem 2002;277:15499–506
- Erdreich-Epstein A, Robison N, Ren X, et al. PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas. Clin Cancer Res 2014;20:827–36
- Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Proc Natl Acad Sci USA 1996;68:850–8
- D’Ambrosio C, Arena S, Salzano AM, et al. A proteomic characterization of water buffalo milk fractions describing PTM of major species and the identification of minor components involved in nutrient delivery and defense against pathogens. Proteomics 2008;8:3657–66
- Villen J, Beausoleil SA, Gerber SA, Gygi SP. Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci USA 2007;104:1488–93
- Trost M, English L, Lemieux S, et al. The phagosomal proteome in interferon-gamma-activated macrophages. Immunity 2009;30:143–54
- Deng WJ, Nie S, Dai J, et al. Proteome, phosphoproteome, and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages. Mol Cell Proteomics 2010;9:100–16
- Meggio F, Pinna LA. One-thousand-and-one substrates of protein kinase CK2? FASEB J 2003;17:349–68
- Lau LF, Nathans D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 1987;84:1182–6
- Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 2005;41:2449–61
- Matsumura I, Tanaka H, Kanakura Y. E2F1 and c-Myc in cell growth and death. Cell Cycle 2003;2:333–8